ALDH1A1 in Cancers: Bidirectional Function, Drug Resistance, and Regulatory Mechanism

Aldehyde dehydrogenases 1 family member A1(ALDH1A1) gene codes a cytoplasmic enzyme and shows vital physiological and pathophysiological functions in many areas. ALDH1A1 plays important roles in various diseases, especially in cancers. We reviewed and summarized representative correlative studies an...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in oncology Vol. 12; p. 918778
Main Authors Yue, Hanxun, Hu, Zenan, Hu, Rui, Guo, Zeying, Zheng, Ya, Wang, Yuping, Zhou, Yongning
Format Journal Article
LanguageEnglish
Published Frontiers Media S.A 22.06.2022
Subjects
aldehyde dehydrogenases
cancer stem cell
carcinogenesis
drug resistance
hepatocellular carcinoma
Oncology
Online AccessGet full text

Cover

Abstract Aldehyde dehydrogenases 1 family member A1(ALDH1A1) gene codes a cytoplasmic enzyme and shows vital physiological and pathophysiological functions in many areas. ALDH1A1 plays important roles in various diseases, especially in cancers. We reviewed and summarized representative correlative studies and found that ALDH1A1 could induce cancers via the maintenance of cancer stem cell properties, modification of metabolism, promotion of DNA repair. ALDH1A1 expression is regulated by several epigenetic processes. ALDH1A1 also acted as a tumor suppressor in certain cancers. The detoxification of ALDH1A1 often causes chemotherapy failure. Currently, ALDH1A1-targeted therapy is widely used in cancer treatment, but the mechanism by which ALDH1A1 regulates cancer development is not fully understood. This review will provide insight into the status of ALDH1A1 research and new viewpoint for cancer therapy.
AbstractList Aldehyde dehydrogenases 1 family member A1(ALDH1A1) gene codes a cytoplasmic enzyme and shows vital physiological and pathophysiological functions in many areas. ALDH1A1 plays important roles in various diseases, especially in cancers. We reviewed and summarized representative correlative studies and found that ALDH1A1 could induce cancers via the maintenance of cancer stem cell properties, modification of metabolism, promotion of DNA repair. ALDH1A1 expression is regulated by several epigenetic processes. ALDH1A1 also acted as a tumor suppressor in certain cancers. The detoxification of ALDH1A1 often causes chemotherapy failure. Currently, ALDH1A1-targeted therapy is widely used in cancer treatment, but the mechanism by which ALDH1A1 regulates cancer development is not fully understood. This review will provide insight into the status of ALDH1A1 research and new viewpoint for cancer therapy.
Aldehyde dehydrogenases 1 family member A1(ALDH1A1) gene codes a cytoplasmic enzyme and shows vital physiological and pathophysiological functions in many areas. ALDH1A1 plays important roles in various diseases, especially in cancers. We reviewed and summarized representative correlative studies and found that ALDH1A1 could induce cancers via the maintenance of cancer stem cell properties, modification of metabolism, promotion of DNA repair. ALDH1A1 expression is regulated by several epigenetic processes. ALDH1A1 also acted as a tumor suppressor in certain cancers. The detoxification of ALDH1A1 often causes chemotherapy failure. Currently, ALDH1A1-targeted therapy is widely used in cancer treatment, but the mechanism by which ALDH1A1 regulates cancer development is not fully understood. This review will provide insight into the status of ALDH1A1 research and new viewpoint for cancer therapy.Aldehyde dehydrogenases 1 family member A1(ALDH1A1) gene codes a cytoplasmic enzyme and shows vital physiological and pathophysiological functions in many areas. ALDH1A1 plays important roles in various diseases, especially in cancers. We reviewed and summarized representative correlative studies and found that ALDH1A1 could induce cancers via the maintenance of cancer stem cell properties, modification of metabolism, promotion of DNA repair. ALDH1A1 expression is regulated by several epigenetic processes. ALDH1A1 also acted as a tumor suppressor in certain cancers. The detoxification of ALDH1A1 often causes chemotherapy failure. Currently, ALDH1A1-targeted therapy is widely used in cancer treatment, but the mechanism by which ALDH1A1 regulates cancer development is not fully understood. This review will provide insight into the status of ALDH1A1 research and new viewpoint for cancer therapy.
Aldehyde dehydrogenases 1 family member A1(ALDH1A1) gene codes a cytoplasmic enzyme and shows vital physiological and pathophysiological functions in many areas. ALDH1A1 plays important roles in various diseases, especially in cancers. We reviewed and summarized representative correlative studies and found that ALDH1A1 could induce cancers via the maintenance of cancer stem cell properties, modification of metabolism, promotion of DNA repair. ALDH1A1 expression is regulated by several epigenetic processes. ALDH1A1 also acted as a tumor suppressor in certain cancers. The detoxification of ALDH1A1 often causes chemotherapy failure. Currently, ALDH1A1-targeted therapy is widely used in cancer treatment, but the mechanism by which ALDH1A1 regulates cancer development is not fully understood. This review will provide insight into the status of ALDH1A1 research and new viewpoint for cancer therapy.
Author Hu, Zenan
Hu, Rui
Zhou, Yongning
Guo, Zeying
Wang, Yuping
Yue, Hanxun
Zheng, Ya
AuthorAffiliation 5 College of Chemistry and Chemical Engineering, Lanzhou University , Lanzhou , China
3 Key Laboratory for Gastrointestinal Diseases of Gansu Province, The First Hospital of Lanzhou University , Lanzhou , China
4 Key Laboratory for Reproductive Medicine and Embryo of Gansu Province, The First Hospital of Lanzhou University , Lanzhou , China
1 The First School of Clinical Medicine, Lanzhou University , Lanzhou , China
2 Department of Gastroenterology, The First Hospital of Lanzhou University , Lanzhou , China
AuthorAffiliation_xml – name: 5 College of Chemistry and Chemical Engineering, Lanzhou University , Lanzhou , China
– name: 4 Key Laboratory for Reproductive Medicine and Embryo of Gansu Province, The First Hospital of Lanzhou University , Lanzhou , China
– name: 1 The First School of Clinical Medicine, Lanzhou University , Lanzhou , China
– name: 3 Key Laboratory for Gastrointestinal Diseases of Gansu Province, The First Hospital of Lanzhou University , Lanzhou , China
– name: 2 Department of Gastroenterology, The First Hospital of Lanzhou University , Lanzhou , China
Author_xml – sequence: 1
  givenname: Hanxun
  surname: Yue
  fullname: Yue, Hanxun
– sequence: 2
  givenname: Zenan
  surname: Hu
  fullname: Hu, Zenan
– sequence: 3
  givenname: Rui
  surname: Hu
  fullname: Hu, Rui
– sequence: 4
  givenname: Zeying
  surname: Guo
  fullname: Guo, Zeying
– sequence: 5
  givenname: Ya
  surname: Zheng
  fullname: Zheng, Ya
– sequence: 6
  givenname: Yuping
  surname: Wang
  fullname: Wang, Yuping
– sequence: 7
  givenname: Yongning
  surname: Zhou
  fullname: Zhou, Yongning
BookMark eNp1kc9rFDEUx4NUbF179zhHD901PyYziQdhu7W2sCKIBW8h8_JmmzKb1GRG6H9vplvBCuaS917e90P4fl-ToxADEvKW0ZUQSr_vY4AVp5yvNFNtq16QE85FvdS1-HH0V31MTnO-o-U0kjIqXpFjIRWrheIn5Ga9vbhia1b5UG1sAEz5Q3XunU8Io4_BDtXlFB7Ls-oiTbvqG2afx3n1rLLBlX43DXaM6aH6gnBrg8_7N-Rlb4eMp0_3gtxcfvq-uVpuv36-3qy3S6iFHpdSo-2AS-QNA8qg17VmnaMSnWbCoaBSydoJLrsGa4201pqiRAWSuxacWJDrA9dFe2fuk9_b9GCi9eZxENPO2DR6GNBYUB202vWobE3bTlGQZeKKc7rVnBXWxwPrfur26ADDmOzwDPr8Jfhbs4u_jOay0cXoBXn3BEjx54R5NHufAYfBBoxTNrxRiqpG0basNodVSDHnhL0BP9rZ5EL2g2HUzBGbOWIzR2wOERch_Uf453__lfwGhjWqfA
CitedBy_id crossref_primary_10_1016_j_hbpd_2024_12_007
crossref_primary_10_1155_ancp_5578693
crossref_primary_10_12677_ACM_2023_1371662
crossref_primary_10_1002_tox_24270
crossref_primary_10_1021_jacsau_4c01001
crossref_primary_10_1021_acs_jproteome_4c00593
crossref_primary_10_1016_j_biopha_2023_115152
crossref_primary_10_3389_fonc_2022_1026278
crossref_primary_10_3390_cancers16244237
crossref_primary_10_1038_s41388_024_02981_x
crossref_primary_10_1038_s44321_024_00081_7
crossref_primary_10_1016_j_bioactmat_2024_02_026
crossref_primary_10_1038_s41698_023_00411_x
crossref_primary_10_3390_diagnostics12112721
crossref_primary_10_3390_ph16121706
crossref_primary_10_3389_fmed_2022_1116908
crossref_primary_10_1055_s_0043_1763751
crossref_primary_10_3389_fcell_2023_1217149
crossref_primary_10_3390_biomedicines11041180
crossref_primary_10_1080_07391102_2023_2218936
crossref_primary_10_1158_1535_7163_MCT_24_0367
crossref_primary_10_1016_j_biopha_2024_116215
crossref_primary_10_1053_j_gastro_2023_02_045
crossref_primary_10_1016_j_biopha_2024_117804
crossref_primary_10_1016_j_theriogenology_2024_04_020
crossref_primary_10_1158_1078_0432_CCR_22_0611
crossref_primary_10_3390_ijms24119372
crossref_primary_10_3390_ijms26010251
crossref_primary_10_3390_cancers16172970
crossref_primary_10_1002_cam4_7004
crossref_primary_10_3892_ol_2025_14959
crossref_primary_10_3390_ijms241210354
crossref_primary_10_3390_ijms26052303
crossref_primary_10_3389_fonc_2023_1222575
crossref_primary_10_1016_j_jds_2023_10_005
crossref_primary_10_3389_fimmu_2025_1513806
crossref_primary_10_3892_ijo_2024_5703
crossref_primary_10_1016_j_cbi_2024_111202
crossref_primary_10_1080_07391102_2023_2300127
Cites_doi 10.1016/j.humpath.2017.06.025
10.1016/j.biopha.2020.109940
10.1016/j.cbi.2019.02.030
10.1186/1477-7819-12-29
10.1371/journal.pone.0182208
10.1096/fj.20211686R
10.1186/1471-2407-14-444
10.3892/ijo.2014.2357
10.1007/s12010-015-1696-x
10.3892/ol.2018.9381
10.1038/cr.2018.15
10.1371/journal.pone.0155160
10.1093/carcin/bgz179
10.1007/s10930-017-9696-z
10.1002/jcp.25706
10.21315/mjms2019.26.5.4
10.18632/oncotarget.6023
10.12659/msm.910109
10.1080/2162402x.2018.1509821
10.3390/cancers11040502
10.3390/diagnostics10070444
10.18632/oncotarget.6920
10.1096/fj.201600263RR
10.1016/j.prp.2017.10.015
10.1111/his.14129
10.1158/1940-6207.Capr-13-0216
10.1007/s12035-018-1114-9
10.1089/scd.2012.0703
10.1136/jclinpath-2015-203092
10.1007/s10549-017-4600-2
10.1016/j.cell.2013.08.055
10.1016/j.bbrc.2015.04.029
10.18632/oncotarget.16430
10.1700/1491.16419
10.18632/oncotarget.4406
10.1016/j.jmgm.2021.107950
10.3389/fmolb.2021.690206
10.3892/ol.2019.10798
10.1016/j.yexcr.2020.112009
10.1016/j.biocel.2016.07.017
10.1016/j.tranon.2018.08.001
10.1016/j.prp.2016.06.009
10.3390/ijms18102039
10.1111/febs.15698
10.1093/dote/dox011
10.1038/onc.2014.178
10.1007/s12032-021-01569-9
10.1186/s13046-018-0975-0
10.3390/antiox6030052
10.1016/j.ajpath.2015.01.011
10.1111/1348-0421.12877
10.1093/bib/bby054
10.5301/jbm.5000165
10.1097/pai.0000000000000343
10.1186/s12915-016-0335-5
10.1038/s41366-021-00818-1
10.1016/j.prp.2016.02.011
10.1016/s0009-2797(02)00204-1
10.1038/s41419-018-0585-y
10.3389/fcell.2020.574394
10.1002/path.5848
10.1007/s13277-013-1099-y
10.1186/s13024-021-00494-9
10.1002/ijc.32505
10.1016/j.pathol.2018.03.002
10.2147/ott.S170858
10.1016/j.bmc.2021.116352
10.1007/s00228-018-2505-6
10.3389/fncir.2021.644776
10.1158/0008-5472.Can-21-1337
10.1111/j.1750-3639.2012.00592.x
10.21873/anticanres.15586
10.4161/cc.10.9.15486
10.1007/s00439-021-02345-5
10.1371/journal.pone.0205536
10.1007/s11306-019-1514-5
10.1007/s11033-021-07073-7
10.1016/j.bcp.2017.07.020
10.1016/j.ejphar.2019.172837
10.1186/1471-2407-14-705
10.1007/s12015-010-9208-4
10.1038/s41375-019-0656-9
10.3892/ijo.2016.3464
10.1038/leu.2014.334
10.1158/0008-5472.Can-16-0854
10.1158/1535-7163.Mct-19-0242
10.1186/s12885-017-3192-x
10.1038/s41598-022-05176-0
10.12659/msm.908022
10.3390/ijms20082053
10.1002/path.5356
10.1038/s41392-020-0110-5
10.2147/cmar.S208708
10.1016/j.anndiagpath.2020.151696
10.1038/s41580-021-00441-y
10.1016/j.ejmech.2020.112940
ContentType Journal Article
Copyright Copyright © 2022 Yue, Hu, Hu, Guo, Zheng, Wang and Zhou.
Copyright © 2022 Yue, Hu, Hu, Guo, Zheng, Wang and Zhou 2022 Yue, Hu, Hu, Guo, Zheng, Wang and Zhou
Copyright_xml – notice: Copyright © 2022 Yue, Hu, Hu, Guo, Zheng, Wang and Zhou.
– notice: Copyright © 2022 Yue, Hu, Hu, Guo, Zheng, Wang and Zhou 2022 Yue, Hu, Hu, Guo, Zheng, Wang and Zhou
DBID AAYXX
CITATION
7X8
5PM
DOA
DOI 10.3389/fonc.2022.918778
DatabaseName CrossRef
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE - Academic
DatabaseTitleList CrossRef
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 2234-943X
ExternalDocumentID oai_doaj_org_article_ac8bc79dfe8a407b80c58bcd87797921
PMC9256994
10_3389_fonc_2022_918778
GroupedDBID 53G
5VS
9T4
AAFWJ
AAKDD
AAYXX
ACGFO
ACGFS
ACXDI
ADBBV
ADRAZ
AFPKN
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BCNDV
CITATION
DIK
EBS
EJD
EMOBN
GROUPED_DOAJ
GX1
HYE
KQ8
M48
M~E
OK1
PGMZT
RNS
RPM
7X8
5PM
ID FETCH-LOGICAL-c439t-59eabc25e261c01cf9491bd05ed913de305854d325b6e49e04990e5e8c52d7cd3
IEDL.DBID M48
ISSN 2234-943X
IngestDate Wed Aug 27 01:26:18 EDT 2025
Thu Aug 21 18:34:36 EDT 2025
Fri Jul 11 03:24:29 EDT 2025
Thu Apr 24 23:08:50 EDT 2025
Tue Jul 01 00:47:30 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Language English
License This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c439t-59eabc25e261c01cf9491bd05ed913de305854d325b6e49e04990e5e8c52d7cd3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
Reviewed by: Junlong Zhuang, Nanjing Drum Tower Hospital, China; Jamal Majidpoor, Iran University of Medical Sciences, Iran
This article was submitted to Cancer Genetics, a section of the journal Frontiers in Oncology
Edited by: Ira Ida Skvortsova, Innsbruck Medical University, Austria
These authors have contributed equally to this work
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.3389/fonc.2022.918778
PMID 35814382
PQID 2688086807
PQPubID 23479
ParticipantIDs doaj_primary_oai_doaj_org_article_ac8bc79dfe8a407b80c58bcd87797921
pubmedcentral_primary_oai_pubmedcentral_nih_gov_9256994
proquest_miscellaneous_2688086807
crossref_citationtrail_10_3389_fonc_2022_918778
crossref_primary_10_3389_fonc_2022_918778
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2022-06-22
PublicationDateYYYYMMDD 2022-06-22
PublicationDate_xml – month: 06
  year: 2022
  text: 2022-06-22
  day: 22
PublicationDecade 2020
PublicationTitle Frontiers in oncology
PublicationYear 2022
Publisher Frontiers Media S.A
Publisher_xml – name: Frontiers Media S.A
References Erfani (B39) 2016; 31
Wu (B59) 2018; 50
Condello (B35) 2015; 34
Yang (B13) 2021; 8
Xu (B25) 2014; 7
Januchowski (B44) 2016; 78
Singh (B98) 2017; 36
Zhao (B62) 2018; 11
Ma (B8) 2021; 46
Namekawa (B80) 2020; 146
Carmichael (B6) 2021; 15
Li (B28) 2014
Yoshino (B79) 2020; 41
Zhou (B94) 2022; 36
Ma (B42) 2016; 48
Wang (B88) 2020; 125
Chanda (B14) 2013; 155
Yassin Fel (B38) 2016; 212
Roy (B66) 2018; 73
Patlolla (B24) 2013; 6
Nachiyappan (B93) 2022; 256
Qiu (B16) 2015; 29
Okudela (B21) 2013; 6
Liu (B31) 2015; 6
Oria (B63) 2018; 11
Marcato (B1) 2011; 10
Narendra (B90) 2021; 38
Yamashita (B92) 2022; 12
Adam (B20) 2012; 22
Charkoftaki (B74) 2019; 304
van der Waals (B54) 2018; 13
Sun (B47) 2017; 30
Nwani (B75) 2019; 11
Xing (B27) 2014
Wang (B4) 2017; 15
Lerner (B7) 2021; 140
Wang (B64) 2018; 28
Wang (B22) 2017; 17
Tomita (B3) 2016; 7
Lu (B48) 2017; 10
Okamoto (B95) 2022; 42
Wang (B67) 2018; 24
Kaipio (B85) 2020; 250
Croker (B45) 2017; 18
Ciccone (B60) 2018; 37
Althobiti (B76) 2020; 77
Kwiatkowska-Borowczyk (B68) 2018; 7
Dancik (B19) 2022; 49
Calleja (B5) 2021; 288
Tanaka (B36) 2015; 6
Wang (B73) 2019; 15
Wang (B40) 2016; 212
Condello (B101) 2015; 34
Wang (B83) 2020; 125
Yu (B49) 2017; 8
Yokoyama (B43) 2016; 76
Nagare (B77) 2020; 392
Chen (B100) 2019; 20
Landrier (B10) 2017; 31
Allison (B52) 2017; 143
Duong (B29) 2014; 44
Gao (B33) 2015; 462
Peng (B96) 2021; 65
Gong (B71) 2019; 11
Ye (B58) 2018; 214
Nikhil (B11) 2019; 56
Liu (B86) 2020; 19
Elcheva (B82) 2020; 34
Narendra (B91) 2021; 107
Cui (B61) 2018; 9
Swierczewska (B72) 2019; 20
Ma (B2) 2011; 7
Szafarowski (B78) 2020; 867
Tulake (B57) 2018; 16
Li (B18) 2021; 209
Haenisch (B9) 2021; 45
Liu (B17) 2014; 14
Wanandi (B70) 2019; 26
Gyan (B87) 2021; 51
Duester (B15) 2003
Tieng (B84) 2020; 10
Duong (B51) 2017; 6
Cao (B26) 2014; 100
Shvedunova (B99) 2022; 23
Hoshino (B34) 2015; 185
Kesharwani (B37) 2015; 176
Liu (B69) 2019; 18
Kalantari (B46) 2017; 25
Patlolla (B102) 2013; 6
Kim (B41) 2016; 11
Yang (B53) 2017; 12
Xia (B56) 2018; 168
Jiang (B81) 2020; 8
Wilson (B23) 2013; 22
Wang (B50) 2017; 232
Yang (B97) 2020; 5
Yang (B55) 2018; 24
Kalra (B65) 2018; 74
Pandrangi (B30) 2014; 35
Liu (B89) 2021; 81
Sjöström (B32) 2015; 68
Li (B12) 2021; 16
References_xml – volume: 73
  start-page: (1
  year: 2018
  ident: B66
  article-title: Aldehyde Dehydrogenase 1A1 (ALDH1A1) Expression by Immunohistochemistry is Associated With Chemo-Refractoriness in Patients With High-Grade Ovarian Serous Carcinoma
  publication-title: Hum Pathol
  doi: 10.1016/j.humpath.2017.06.025
– volume: 125
  start-page: (109940)
  year: 2020
  ident: B88
  article-title: ALDH1A1 Maintains the Cancer Stem-Like Cells Properties of Esophageal Squamous Cell Carcinoma by Activating the AKT Signal Pathway and Interacting With β-Catenin
  publication-title: BioMed Pharmacother
  doi: 10.1016/j.biopha.2020.109940
– volume: 304
  start-page: (88
  year: 2019
  ident: B74
  article-title: Integrated Multi-Omics Approach Reveals a Role of ALDH1A1 in Lipid Metabolism in Human Colon Cancer Cells
  publication-title: Chem Biol Interact
  doi: 10.1016/j.cbi.2019.02.030
– start-page: 12(29)
  year: 2014
  ident: B27
  article-title: High ALDH1A1 Expression Correlates With Poor Survival in Papillary Thyroid Carcinoma
  publication-title: World J Surg Oncol
  doi: 10.1186/1477-7819-12-29
– volume: 12
  year: 2017
  ident: B53
  article-title: Aldehyde Dehydrogenase 1 (ALDH1) Isoform Expression and Potential Clinical Implications in Hepatocellular Carcinoma
  publication-title: PloS One
  doi: 10.1371/journal.pone.0182208
– volume: 36
  year: 2022
  ident: B94
  article-title: Liver Regeneration and Ethanol Detoxification: A New Link in YAP Regulation of ALDH1A1 During Alcohol-Related Hepatocyte Damage
  publication-title: FASEB J
  doi: 10.1096/fj.20211686R
– volume: 14
  year: 2014
  ident: B17
  article-title: ALDH1A1 Expression Correlates With Clinicopathologic Features and Poor Prognosis of Breast Cancer Patients: A Systematic Review and Meta-Analysis
  publication-title: BMC Cancer
  doi: 10.1186/1471-2407-14-444
– volume: 44
  year: 2014
  ident: B29
  article-title: Combination of Dasatinib and Gemcitabine Reduces the ALDH1A1 Expression and the Proliferation of Gemcitabine-Resistant Pancreatic Cancer MIA PaCa-2 Cells
  publication-title: Int J Oncol
  doi: 10.3892/ijo.2014.2357
– volume: 176
  start-page: 1996
  year: 2015
  ident: B37
  article-title: A Novel Approach for Overcoming Drug Resistance in Breast Cancer Chemotherapy by Targeting New Synthetic Curcumin Analogues Against Aldehyde Dehydrogenase 1 (ALDH1A1) and Glycogen Synthase Kinase-3 Beta (GSK-3beta)
  publication-title: Appl Biochem Biotechnol
  doi: 10.1007/s12010-015-1696-x
– volume: 16
  year: 2018
  ident: B57
  article-title: Upregulation of Stem Cell Markers ALDH1A1 and OCT4 as Potential Biomarkers for the Early Detection of Cervical Carcinoma
  publication-title: Oncol Lett
  doi: 10.3892/ol.2018.9381
– volume: 28
  year: 2018
  ident: B64
  article-title: Tamoxifen Enhances Stemness and Promotes Metastasis of ERalpha36(+) Breast Cancer by Upregulating ALDH1A1 in Cancer Cells
  publication-title: Cell Res
  doi: 10.1038/cr.2018.15
– volume: 11
  year: 2016
  ident: B41
  article-title: Complex Behavior of ALDH1A1 and IGFBP1 in Liver Metastasis From a Colorectal Cancer
  publication-title: PloS One
  doi: 10.1371/journal.pone.0155160
– volume: 41
  year: 2020
  ident: B79
  article-title: Loss of ARID1A Induces a Stemness Gene ALDH1A1 Expression With Histone Acetylation in the Malignant Subtype of Cholangiocarcinoma
  publication-title: Carcinogenesis
  doi: 10.1093/carcin/bgz179
– volume: 36
  start-page: 1
  year: 2017
  ident: B98
  article-title: Phosphorylation: Implications in Cancer
  publication-title: Protein J
  doi: 10.1007/s10930-017-9696-z
– volume: 232
  year: 2017
  ident: B50
  article-title: NOR1 Suppresses Cancer Stem-Like Cells Properties of Tumor Cells via the Inhibition of the AKT-GSK-3beta-Wnt/beta-Catenin-ALDH1A1 Signal Circuit
  publication-title: J Cell Physiol
  doi: 10.1002/jcp.25706
– volume: 26
  start-page: 38
  year: 2019
  ident: B70
  article-title: Profiling of Gene Expression Associated With Stemness and Aggressiveness of ALDH1A1-Expressing Human Breast Cancer Cells
  publication-title: Malays J Med Sci
  doi: 10.21315/mjms2019.26.5.4
– volume: 6
  year: 2015
  ident: B31
  article-title: ALDH1A1 mRNA Expression in Association With Prognosis of Triple-Negative Breast Cancer
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.6023
– volume: 24
  year: 2018
  ident: B55
  article-title: Expression of Aldehyde Dehydrogenase 1a1 (ALDH1A1) as a Prognostic Biomarker in Colorectal Cancer Using Immunohistochemistry
  publication-title: Med Sci Monit
  doi: 10.12659/msm.910109
– volume: 7
  year: 2018
  ident: B68
  article-title: Whole Cell Melanoma Vaccine Genetically Modified to Stem Cells Like Phenotype Generates Specific Immune Responses to ALDH1A1 and Long-Term Survival in Advanced Melanoma Patients
  publication-title: Oncoimmunology
  doi: 10.1080/2162402x.2018.1509821
– volume: 11
  start-page: 502
  year: 2019
  ident: B75
  article-title: A Novel ALDH1A1 Inhibitor Targets Cells With Stem Cell Characteristics in Ovarian Cancer
  publication-title: Cancers (Basel)
  doi: 10.3390/cancers11040502
– volume: 10
  start-page: 444
  year: 2020
  ident: B84
  article-title: L1CAM, CA9, KLK6, HPN, and ALDH1A1 as Potential Serum Markers in Primary and Metastatic Colorectal Cancer Screening
  publication-title: Diagnostics (Basel)
  doi: 10.3390/diagnostics10070444
– volume: 7
  year: 2016
  ident: B3
  article-title: Aldehyde Dehydrogenase 1A1 in Stem Cells and Cancer
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.6920
– volume: 31
  year: 2017
  ident: B10
  article-title: Reduced Adiponectin Expression After High-Fat Diet is Associated With Selective Up-Regulation of ALDH1A1 and Further Retinoic Acid Receptor Signaling in Adipose Tissue
  publication-title: FASEB J
  doi: 10.1096/fj.201600263RR
– volume: 214
  year: 2018
  ident: B58
  article-title: High ALDH1A1 Expression Indicates a Poor Prognosis in Gastric Neuroendocrine Carcinoma
  publication-title: Pathol Res Pract
  doi: 10.1016/j.prp.2017.10.015
– volume: 77
  year: 2020
  ident: B76
  article-title: The Prognostic Significance of ALDH1A1 Expression in Early Invasive Breast Cancer
  publication-title: Histopathology
  doi: 10.1111/his.14129
– volume: 6
  year: 2013
  ident: B102
  article-title: Beta-Escin Inhibits NNK-Induced Lung Adenocarcinoma and ALDH1A1 and RhoA/Rock Expression in a/J Mice and Growth of H460 Human Lung Cancer Cells
  publication-title: Cancer Prev Res (Phila)
  doi: 10.1158/1940-6207.Capr-13-0216
– volume: 56
  year: 2019
  ident: B11
  article-title: Multifaceted Regulation of ALDH1A1 by Cdk5 in Alzheimer’s Disease Pathogenesis
  publication-title: Mol Neurobiol
  doi: 10.1007/s12035-018-1114-9
– volume: 22
  year: 2013
  ident: B23
  article-title: Efficacy of Using Cancer Stem Cell Markers in Isolating and Characterizing Liver Cancer Stem Cells
  publication-title: Stem Cells Dev
  doi: 10.1089/scd.2012.0703
– volume: 68
  year: 2015
  ident: B32
  article-title: Stem Cell Biomarker ALDH1A1 in Breast Cancer Shows an Association With Prognosis and Clinicopathological Variables That is Highly Cut-Off Dependent
  publication-title: J Clin Pathol
  doi: 10.1136/jclinpath-2015-203092
– volume: 168
  year: 2018
  ident: B56
  article-title: Associations Between ALDH1A1 Polymorphisms, Alcohol Consumption, and Mortality Among Hispanic and non-Hispanic White Women Diagnosed With Breast Cancer: The Breast Cancer Health Disparities Study
  publication-title: Breast Cancer Res Treat
  doi: 10.1007/s10549-017-4600-2
– volume: 155
  year: 2013
  ident: B14
  article-title: Retinoic Acid Signaling is Essential for Embryonic Hematopoietic Stem Cell Development
  publication-title: Cell
  doi: 10.1016/j.cell.2013.08.055
– volume: 462
  year: 2015
  ident: B33
  article-title: The Role of LGR5 and ALDH1A1 in non-Small Cell Lung Cancer: Cancer Progression and Prognosis
  publication-title: Biochem Biophys Res Commun
  doi: 10.1016/j.bbrc.2015.04.029
– volume: 8
  year: 2017
  ident: B49
  article-title: TAZ Induces Lung Cancer Stem Cell Properties and Tumorigenesis by Up-Regulating ALDH1A1
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.16430
– volume: 7
  year: 2014
  ident: B25
  article-title: Distinct Patterns of ALDH1A1 Expression Predict Metastasis and Poor Outcome of Colorectal Carcinoma
  publication-title: Int J Clin Exp Pathol
– volume: 100
  year: 2014
  ident: B26
  article-title: Serum ALDH1A1 is a Tumor Marker for the Diagnosis of non-Small Cell Lung Cancer
  publication-title: Tumori
  doi: 10.1700/1491.16419
– volume: 6
  year: 2015
  ident: B36
  article-title: ALDH1A1-Overexpressing Cells are Differentiated Cells But Not Cancer Stem or Progenitor Cells in Human Hepatocellular Carcinoma
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.4406
– volume: 107
  start-page: (107950)
  year: 2021
  ident: B91
  article-title: Multiple Machine Learning Models Combined With Virtual Screening and Molecular Docking to Identify Selective Human ALDH1A1 Inhibitors
  publication-title: J Mol Graph Model
  doi: 10.1016/j.jmgm.2021.107950
– volume: 8
  year: 2021
  ident: B13
  article-title: Angiogenesis-Related Immune Signatures Correlate With Prognosis, Tumor Microenvironment, and Therapeutic Sensitivity in Hepatocellular Carcinoma
  publication-title: Front Mol Biosci
  doi: 10.3389/fmolb.2021.690206
– volume: 18
  year: 2019
  ident: B69
  article-title: Expression of ALDH1A1 and CD133 is Associated With the Prognosis and Effect of Different Chemotherapeutic Regimens in Gastric Cancer
  publication-title: Oncol Lett
  doi: 10.3892/ol.2019.10798
– volume: 392
  year: 2020
  ident: B77
  article-title: ALDH1A1+ Ovarian Cancer Stem Cells Co-Expressing Surface Markers CD24, EPHA1 and CD9 Form Tumours In Vivo
  publication-title: Exp Cell Res
  doi: 10.1016/j.yexcr.2020.112009
– volume: 78
  year: 2016
  ident: B44
  article-title: Inhibition of ALDH1A1 Activity Decreases Expression of Drug Transporters and Reduces Chemotherapy Resistance in Ovarian Cancer Cell Lines
  publication-title: Int J Biochem Cell Biol
  doi: 10.1016/j.biocel.2016.07.017
– volume: 11
  year: 2018
  ident: B63
  article-title: Proteome Profiling of Primary Pancreatic Ductal Adenocarcinomas Undergoing Additive Chemoradiation Link ALDH1A1 to Early Local Recurrence and Chemoradiation Resistance
  publication-title: Transl Oncol
  doi: 10.1016/j.tranon.2018.08.001
– volume: 212
  year: 2016
  ident: B40
  article-title: Nuclear Aldehyde Dehydrogenase 1A1 (ALDH1A1) Expression is a Favorable Prognostic Indicator in Colorectal Carcinoma
  publication-title: Pathol Res Pract
  doi: 10.1016/j.prp.2016.06.009
– volume: 18
  start-page: 2039
  year: 2017
  ident: B45
  article-title: Differential Functional Roles of ALDH1A1 and ALDH1A3 in Mediating Metastatic Behavior and Therapy Resistance of Human Breast Cancer Cells
  publication-title: Int J Mol Sci
  doi: 10.3390/ijms18102039
– volume: 288
  year: 2021
  ident: B5
  article-title: Activation of ALDH1A1 by Omeprazole Reduces Cell Oxidative Stress Damage
  publication-title: FEBS J
  doi: 10.1111/febs.15698
– volume: 30
  start-page: 1
  year: 2017
  ident: B47
  article-title: Associations of Carboxypeptidase 4 With ALDH1A1 Expression and Their Prognostic Value in Esophageal Squamous Cell Carcinoma
  publication-title: Esophagus
  doi: 10.1093/dote/dox011
– volume: 34
  year: 2015
  ident: B35
  article-title: β-Catenin-Regulated ALDH1A1 is a Target in Ovarian Cancer Spheroids
  publication-title: Oncogene
  doi: 10.1038/onc.2014.178
– volume: 38
  start-page: 123
  year: 2021
  ident: B90
  article-title: Identification of Potential Genes Associated With ALDH1A1 Overexpression and Cyclophosphamide Resistance in Chronic Myelogenous Leukemia Using Network Analysis
  publication-title: Med Oncol
  doi: 10.1007/s12032-021-01569-9
– volume: 37
  start-page: 311
  year: 2018
  ident: B60
  article-title: Stemness Marker ALDH1A1 Promotes Tumor Angiogenesis via Retinoic Acid/HIF-1alpha/VEGF Signalling in MCF-7 Breast Cancer Cells
  publication-title: J Exp Clin Cancer Res
  doi: 10.1186/s13046-018-0975-0
– volume: 6
  start-page: 52
  year: 2017
  ident: B51
  article-title: Silencing of NRF2 Reduces the Expression of ALDH1A1 and ALDH3A1 and Sensitizes to 5-FU in Pancreatic Cancer Cells
  publication-title: Antioxidants (Basel)
  doi: 10.3390/antiox6030052
– volume: 185
  year: 2015
  ident: B34
  article-title: Smad4 Decreases the Population of Pancreatic Cancer-Initiating Cells Through Transcriptional Repression of ALDH1A1
  publication-title: Am J Pathol
  doi: 10.1016/j.ajpath.2015.01.011
– volume: 65
  year: 2021
  ident: B96
  article-title: Prospective Study of ALDH1A1 Gene Polymorphisms Associated With Antituberculosis Drug-Induced Liver Injury in Western Chinese Han Population
  publication-title: Microbiol Immunol
  doi: 10.1111/1348-0421.12877
– volume: 20
  year: 2019
  ident: B100
  article-title: Trends in the Development of miRNA Bioinformatics Tools
  publication-title: Brief Bioinform
  doi: 10.1093/bib/bby054
– volume: 10
  year: 2017
  ident: B48
  article-title: DKK1 Maintained Cancer Stem-Like Properties of Esophageal Carcinoma Cells via ALDH1A1/SOX2 Axis
  publication-title: Int J Clin Exp Pathol
– volume: 31
  year: 2016
  ident: B39
  article-title: Comparative Expression Analysis of Putative Cancer Stem Cell Markers CD44 and ALDH1A1 in Various Skin Cancer Subtypes
  publication-title: Int J Biol Markers
  doi: 10.5301/jbm.5000165
– volume: 125
  start-page: (109940)
  year: 2020
  ident: B83
  article-title: ALDH1A1 Maintains the Cancer Stem-Like Cells Properties of Esophageal Squamous Cell Carcinoma by Activating the AKT Signal Pathway and Interacting With Beta-Catenin
  publication-title: BioMed Pharmacother
  doi: 10.1016/j.biopha.2020.109940
– volume: 25
  year: 2017
  ident: B46
  article-title: Increased Expression of ALDH1A1 in Prostate Cancer is Correlated With Tumor Aggressiveness: A Tissue Microarray Study of Iranian Patients
  publication-title: Appl Immunohistochem Mol Morphol
  doi: 10.1097/pai.0000000000000343
– volume: 15
  year: 2017
  ident: B4
  article-title: Phosphorylation-Dependent Regulation of ALDH1A1 by Aurora Kinase A: Insights on Their Synergistic Relationship in Pancreatic Cancer
  publication-title: BMC Biol
  doi: 10.1186/s12915-016-0335-5
– volume: 45
  year: 2021
  ident: B9
  article-title: Investigation of an ALDH1A1-Specific Inhibitor for Suppression of Weight Gain in a Diet-Induced Mouse Model of Obesity
  publication-title: Int J Obes (Lond)
  doi: 10.1038/s41366-021-00818-1
– volume: 212
  start-page: 398
  year: 2016
  ident: B38
  article-title: Aldehyde Dehyderogenase (ALDH1A1) Delineating the Normal and Cancer Stem Cells in Spectral Lung Lesions: An Immunohistochemical Appraisal
  publication-title: Pathol Res Pract
  doi: 10.1016/j.prp.2016.02.011
– year: 2003
  ident: B15
  article-title: Cytosolic Retinoid Dehydrogenases Govern Ubiquitous Metabolism of Retinol to Retinaldehyde Followed by Tissue-Specific Metabolism to Retinoic Acid
  publication-title: Chem Biol Interact
  doi: 10.1016/s0009-2797(02)00204-1
– volume: 9
  start-page: 561
  year: 2018
  ident: B61
  article-title: DDB2 Represses Ovarian Cancer Cell Dedifferentiation by Suppressing ALDH1A1
  publication-title: Cell Death Dis
  doi: 10.1038/s41419-018-0585-y
– volume: 8
  year: 2020
  ident: B81
  article-title: Silybin Prevents Prostate Cancer by Inhibited the ALDH1A1 Expression in the Retinol Metabolism Pathway
  publication-title: Front Cell Dev Biol
  doi: 10.3389/fcell.2020.574394
– volume: 256
  year: 2022
  ident: B93
  article-title: EHMT1 Promotes Tumor Progression and Maintains Stemness by Regulating ALDH1A1 Expression in Alveolar Rhabdomyosarcoma
  publication-title: J Pathol
  doi: 10.1002/path.5848
– volume: 35
  year: 2014
  ident: B30
  article-title: Effects of Ellipticine on ALDH1A1-Expressing Breast Cancer Stem Cells–an In Vitro and in Silico Study
  publication-title: Tumour Biol
  doi: 10.1007/s13277-013-1099-y
– volume: 16
  start-page: 73
  year: 2021
  ident: B12
  article-title: Synaptic Dysfunction of Aldh1a1 Neurons in the Ventral Tegmental Area Causes Impulsive Behaviors
  publication-title: Mol Neurodegener
  doi: 10.1186/s13024-021-00494-9
– volume: 146
  year: 2020
  ident: B80
  article-title: ALDH1A1 in Patient-Derived Bladder Cancer Spheroids Activates Retinoic Acid Signaling Leading to TUBB3 Overexpression and Tumor Progression
  publication-title: Int J Cancer
  doi: 10.1002/ijc.32505
– volume: 50
  year: 2018
  ident: B59
  article-title: ALDH1A1 Positive Cells are a Unique Component of the Tonsillar Crypt Niche and are Lost Along With NGFR Positive Stem Cells During Tumourigenesis
  publication-title: Pathology
  doi: 10.1016/j.pathol.2018.03.002
– volume: 11
  year: 2018
  ident: B62
  article-title: YAP Regulates ALDH1A1 Expression and Stem Cell Property of Bladder Cancer Cells
  publication-title: Onco Targets Ther
  doi: 10.2147/ott.S170858
– volume: 46
  year: 2021
  ident: B8
  article-title: Discovery of Benzimidazole Derivatives as Potent and Selective Aldehyde Dehydrogenase 1A1 (ALDH1A1) Inhibitors With Glucose Consumption Improving Activity
  publication-title: Bioorg Med Chem
  doi: 10.1016/j.bmc.2021.116352
– volume: 74
  year: 2018
  ident: B65
  article-title: Association of CYP2C19*2 and ALDH1A1*1/*2 Variants With Disease Outcome in Breast Cancer Patients: Results of a Global Screening Array
  publication-title: Eur J Clin Pharmacol
  doi: 10.1007/s00228-018-2505-6
– volume: 15
  year: 2021
  ident: B6
  article-title: Function and Regulation of ALDH1A1-Positive Nigrostriatal Dopaminergic Neurons in Motor Control and Parkinson’s Disease
  publication-title: Front Neural Circuits
  doi: 10.3389/fncir.2021.644776
– volume: 81
  year: 2021
  ident: B89
  article-title: ALDH1A1 Activity in Tumor-Initiating Cells Remodels Myeloid-Derived Suppressor Cells to Promote Breast Cancer Progression
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.Can-21-1337
– volume: 22
  year: 2012
  ident: B20
  article-title: ALDH1A1 is a Marker of Astrocytic Differentiation During Brain Development and Correlates With Better Survival in Glioblastoma Patients
  publication-title: Brain Pathol
  doi: 10.1111/j.1750-3639.2012.00592.x
– volume: 42
  year: 2022
  ident: B95
  article-title: Identification of Breast Cancer Stem Cells Using a Newly Developed Long-Acting Fluorescence Probe, C5S-A, Targeting ALDH1A1
  publication-title: Anticancer Res
  doi: 10.21873/anticanres.15586
– volume: 10
  year: 2011
  ident: B1
  article-title: Aldehyde Dehydrogenase: Its Role as a Cancer Stem Cell Marker Comes Down to the Specific Isoform
  publication-title: Cell Cycle
  doi: 10.4161/cc.10.9.15486
– volume: 140
  year: 2021
  ident: B7
  article-title: ASL Expression in ALDH1A1(+) Neurons in the Substantia Nigra Metabolically Contributes to Neurodegenerative Phenotype
  publication-title: Hum Genet
  doi: 10.1007/s00439-021-02345-5
– volume: 13
  year: 2018
  ident: B54
  article-title: ALDH1A1 Expression is Associated With Poor Differentiation, ‘Right-Sidedness’ and Poor Survival in Human Colorectal Cancer
  publication-title: PloS One
  doi: 10.1371/journal.pone.0205536
– volume: 15
  start-page: 52
  year: 2019
  ident: B73
  article-title: UPLC-MS-Based Metabolomics Reveals Metabolic Dysregulation in ALDH1A1-Overexpressed Lung Adenocarcinoma Cells
  publication-title: Metabolomics
  doi: 10.1007/s11306-019-1514-5
– volume: 49
  year: 2022
  ident: B19
  article-title: Lower RNA Expression of ALDH1A1 Distinguishes the Favorable Risk Group in Acute Myeloid Leukemia
  publication-title: Mol Biol Rep
  doi: 10.1007/s11033-021-07073-7
– volume: 143
  start-page: (79
  year: 2017
  ident: B52
  article-title: Activation of ALDH1A1 in MDA-MB-468 Breast Cancer Cells That Over-Express CYP2J2 Protects Against Paclitaxel-Dependent Cell Death Mediated by Reactive Oxygen Species
  publication-title: Biochem Pharmacol
  doi: 10.1016/j.bcp.2017.07.020
– volume: 867
  start-page: (172837)
  year: 2020
  ident: B78
  article-title: Assessment of Cancer Stem Cell Marker Expression in Primary Head and Neck Squamous Cell Carcinoma Shows Prognostic Value for Aldehyde Dehydrogenase (ALDH1A1)
  publication-title: Eur J Pharmacol
  doi: 10.1016/j.ejphar.2019.172837
– start-page: 14(705)
  year: 2014
  ident: B28
  article-title: ALDH1A1 Overexpression is Associated With the Progression and Prognosis in Gastric Cancer
  publication-title: BMC Cancer
  doi: 10.1186/1471-2407-14-705
– volume: 7
  start-page: 292
  year: 2011
  ident: B2
  article-title: The Role of Human Aldehyde Dehydrogenase in Normal and Cancer Stem Cells
  publication-title: Stem Cell Rev Rep
  doi: 10.1007/s12015-010-9208-4
– volume: 34
  year: 2020
  ident: B82
  article-title: RNA-Binding Protein IGF2BP1 Maintains Leukemia Stem Cell Properties by Regulating HOXB4, MYB, and ALDH1A1
  publication-title: Leukemia
  doi: 10.1038/s41375-019-0656-9
– volume: 48
  year: 2016
  ident: B42
  article-title: Blockade of Notch3 Inhibits the Stem-Like Property and is Associated With ALDH1A1 and CD44 via Autophagy in non-Small Lung Cancer
  publication-title: Int J Oncol
  doi: 10.3892/ijo.2016.3464
– volume: 29
  year: 2015
  ident: B16
  article-title: Critical Role of Retinoid/Rexinoid Signaling in Mediating Transformation and Therapeutic Response of NUP98-RARG Leukemia
  publication-title: Leukemia
  doi: 10.1038/leu.2014.334
– volume: 6
  year: 2013
  ident: B24
  article-title: β-Escin Inhibits NNK-Induced Lung Adenocarcinoma and ALDH1A1 and RhoA/Rock Expression in a/J Mice and Growth of H460 Human Lung Cancer Cells
  publication-title: Cancer Prev Res (Phila)
  doi: 10.1158/1940-6207.Capr-13-0216
– volume: 76
  year: 2016
  ident: B43
  article-title: BET Inhibitors Suppress ALDH Activity by Targeting ALDH1A1 Super-Enhancer in Ovarian Cancer
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.Can-16-0854
– volume: 19
  start-page: 199
  year: 2020
  ident: B86
  article-title: ALDH1A1 Contributes to PARP Inhibitor Resistance via Enhancing DNA Repair in BRCA2(-/-) Ovarian Cancer Cells
  publication-title: Mol Cancer Ther
  doi: 10.1158/1535-7163.Mct-19-0242
– volume: 17
  start-page: 292
  year: 2017
  ident: B22
  article-title: MiR-23b Controls ALDH1A1 Expression in Cervical Cancer Stem Cells
  publication-title: BMC Cancer
  doi: 10.1186/s12885-017-3192-x
– volume: 12
  start-page: 1473
  year: 2022
  ident: B92
  article-title: Triple-Negative Expression (ALDH1A1-/CD133-/Mutant P53-) Cases in Lung Adenocarcinoma had a Good Prognosis
  publication-title: Sci Rep
  doi: 10.1038/s41598-022-05176-0
– volume: 24
  year: 2018
  ident: B67
  article-title: Quercetin Inhibits Breast Cancer Stem Cells via Downregulation of Aldehyde Dehydrogenase 1a1 (ALDH1A1), Chemokine Receptor Type 4 (CXCR4), Mucin 1 (MUC1), and Epithelial Cell Adhesion Molecule (EpCAM)
  publication-title: Med Sci Monit
  doi: 10.12659/msm.908022
– volume: 20
  start-page: 2053
  year: 2019
  ident: B72
  article-title: PTPRK Expression Is Downregulated in Drug Resistant Ovarian Cancer Cell Lines, and Especially in ALDH1A1 Positive CSCs-Like Populations
  publication-title: Int J Mol Sci
  doi: 10.3390/ijms20082053
– volume: 250
  year: 2020
  ident: B85
  article-title: ALDH1A1-Related Stemness in High-Grade Serous Ovarian Cancer is a Negative Prognostic Indicator But Potentially Targetable by EGFR/mTOR-PI3K/aurora Kinase Inhibitors
  publication-title: J Pathol
  doi: 10.1002/path.5356
– volume: 5
  year: 2020
  ident: B97
  article-title: Targeting Cancer Stem Cell Pathways for Cancer Therapy
  publication-title: Signal Transduct Target Ther
  doi: 10.1038/s41392-020-0110-5
– volume: 34
  year: 2015
  ident: B101
  article-title: Beta-Catenin-Regulated ALDH1A1 is a Target in Ovarian Cancer Spheroids
  publication-title: Oncogene
  doi: 10.1038/onc.2014.178
– volume: 11
  year: 2019
  ident: B71
  article-title: miR-625 Reverses Multidrug Resistance in Gastric Cancer Cells by Directly Targeting ALDH1A1
  publication-title: Cancer Manag Res
  doi: 10.2147/cmar.S208708
– volume: 51
  start-page: (151696)
  year: 2021
  ident: B87
  article-title: The Role of ALDH1A1 in Contributing to Breast Tumour Aggressiveness: A Study Conducted in an African Population
  publication-title: Ann Diagn Pathol
  doi: 10.1016/j.anndiagpath.2020.151696
– volume: 23
  year: 2022
  ident: B99
  article-title: Modulation of Cellular Processes by Histone and non-Histone Protein Acetylation
  publication-title: Nat Rev Mol Cell Biol
  doi: 10.1038/s41580-021-00441-y
– volume: 6
  start-page: 1
  year: 2013
  ident: B21
  article-title: Downregulation of ALDH1A1 Expression in non-Small Cell Lung Carcinomas–its Clinicopathologic and Biological Significance
  publication-title: Int J Clin Exp Pathol
– volume: 209
  start-page: (112940)
  year: 2021
  ident: B18
  article-title: Discovery and Development of Selective Aldehyde Dehydrogenase 1A1 (ALDH1A1) Inhibitors
  publication-title: Eur J Med Chem
  doi: 10.1016/j.ejmech.2020.112940
SSID ssj0000650103
Score 2.4956477
SecondaryResourceType review_article
Snippet Aldehyde dehydrogenases 1 family member A1(ALDH1A1) gene codes a cytoplasmic enzyme and shows vital physiological and pathophysiological functions in many...
SourceID doaj
pubmedcentral
proquest
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Enrichment Source
Index Database
StartPage 918778
SubjectTerms aldehyde dehydrogenases
cancer stem cell
carcinogenesis
drug resistance
hepatocellular carcinoma
Oncology
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV07T8MwELYQA2JBPEV5yUgsSA2NnTi22VqgqhBlQFTqZiW2A5UgRX0M_HvukoCaBRYyJY6jOHe2v-9i3x0hFwArFogqC6IkzAPAaxZkwCOCyAHayDxKWY6-w8PHZDCK78divJLqC_eEVeGBK8F1UqsyK7XLvUrB-MhUaAWUOCWllrp0IeeAeSvGVDUHC0xgUK1LghWmO_m0wIiFnF9pBs-qBg6V4fobHLO5Q3IFcvrbZKvmirRbtXGHrPlil2wM69XwPTLqPtwOWJfRSUFvUHuz-TXtTSqUKn_x0T7AFp626e1s-UKf_Bz5IlRt07RwcF1mop_OPunQow_wZP6-T0b9u-ebQVCnSQgssIlFILRPM8uFB2PIhszmOtYsc6HwTrPIeRjRSsQu4iJLfKw9GjmhFx6UxJ20Ljog68W08IeEKu1BUQKOOI9ZLjOWchdrdFeNANdVi3S-hWZsHUMcU1m8GbAlUMwGxWxQzKYSc4tc_jzxUcXP-KVuD_XwUw8jX5cF0B9M3R_MX_2hRc6_tWhgpODyR1r46XJueAJzlUpUKFtENtTbeGPzTjF5LWNua6CGWsdH_9HEY7KJX40bzjg_IeuL2dKfArVZZGdlL_4Cg3n2Ow
  priority: 102
  providerName: Directory of Open Access Journals
Title ALDH1A1 in Cancers: Bidirectional Function, Drug Resistance, and Regulatory Mechanism
URI https://www.proquest.com/docview/2688086807
https://pubmed.ncbi.nlm.nih.gov/PMC9256994
https://doaj.org/article/ac8bc79dfe8a407b80c58bcd87797921
Volume 12
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEBZtCiGX0iYt3T6CArkU4sSSJUsqlLJJullKNofQhb0JW5KThdRu7V1o_n1nbCeNIfRQH4wtS37MePx9Y0kzhOwDrDggqixK0riIAK9ZlAOPiBIPaKOKJGMFzh2eXaTTufi2kIu_06N7ATaPunaYT2pe3xz-_nX7BQz-M3qcgLdHRVViMELODw3TSumn5BngkkIznfVkv_suS0xq0PVVPtpwi2xiODDRhuV7AFNtNP8BBR0OoHyASJMX5HlPJem40_1L8iSU22Rz1neW75D5-Px0ysaMLkt6gsqtm0_0eNmBWPsHkE4A1XDzgJ7W6yt6GRqkk1D1gGalh_02UX1V39JZwCnCy-bHKzKffP1-Mo36LAqRA7KxiqQJWe64DOAruZi5wgjDch_L4A1LfACD11L4hMs8DcIE9IHiIAPokHvlfPKabJRVGd4Qqk0APUpYRCFYoXKWcS8MzmZNAPb1iBzdCc26PsQ4Zrq4seBqoMQtStyixG0n8RH5eN_iZxde4x91j1EP9_UwMHZbUNVXtrczmzmdO2V8EXQGvmquYyehxMMJ4D45G5G9Oy1aMCTsHcnKUK0by1P4lOlUx2pE1EC9gysOj5TL6zYktwHmaIx4-98t35EtfFQchMb5e7KxqtfhA9CdVb7b_iaA9dmC7bZv9B82uf_T
linkProvider Scholars Portal
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=ALDH1A1+in+Cancers%3A+Bidirectional+Function%2C+Drug+Resistance%2C+and+Regulatory+Mechanism&rft.jtitle=Frontiers+in+oncology&rft.au=Yue%2C+Hanxun&rft.au=Hu%2C+Zenan&rft.au=Hu%2C+Rui&rft.au=Guo%2C+Zeying&rft.date=2022-06-22&rft.pub=Frontiers+Media+S.A&rft.eissn=2234-943X&rft.volume=12&rft_id=info:doi/10.3389%2Ffonc.2022.918778&rft_id=info%3Apmid%2F35814382&rft.externalDocID=PMC9256994
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2234-943X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2234-943X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2234-943X&client=summon